Skip to main content
Brian Wolpin, MD, Oncology, Boston, MA

Brian M Wolpin MD


Assistant Professor of Medicine, Dana-Farber Cancer Institute

Join to View Full Profile
  • 450 Brookine Ave, D1220Dana Farber Cancer InstituteBoston, MA 02215

  • Phone+1 617-632-6942

  • Fax+1 617-632-5370

Dr. Wolpin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2004 - 2006
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2001 - 2004
  • Harvard Medical School
    Harvard Medical SchoolClass of 2001

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2003 - 2026
  • NH State Medical License
    NH State Medical License 2024 - 2026
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Diabetes, Weight Change, and Pancreatic Cancer Risk  
    Douglas A Rubinson, Kimmie Ng, Meir J Stampfer, Brian M Wolpin, JAMA Oncology
  • Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic Cancer  
    Richard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature
  • Altered Exocrine Function Can Drive Adipose Wasting in Early Pancreatic Cancer  
    Jared R Mayers, Naoki Takahashi, Nicole Lopez, Brian M Wolpin, Nature

Lectures

  • Performance of a blood-based test for the detection of multiple cancer types. 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020

Authored Content

  • Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
  • Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
  • Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
  • Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
  • Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
  • Join now to see all

Press Mentions

  • New Treatments Give Hope to Patients with One of the Deadliest Cancers
    New Treatments Give Hope to Patients with One of the Deadliest CancersMarch 10th, 2025
  • New Treatments Give Hope to Patients with One of the Deadliest Cancers
    New Treatments Give Hope to Patients with One of the Deadliest CancersFebruary 28th, 2025
  • Don't Ignore These Pancreatic Cancer Warning Signs
    Don't Ignore These Pancreatic Cancer Warning SignsApril 28th, 2023
  • Join now to see all

Grant Support

  • Altered metabolism and machine learning for pancreatic cancer early detectionDANA-FARBER CANCER INST2022–2027
  • Altered metabolism and machine learning for pancreatic cancer early detectionDANA-FARBER CANCER INST2022–2027
  • Cohort Study Of Biochemical And Genetic Risk Factors For Pancreatic CancerNational Cancer Institute2009–2011

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: